Eye rolling as a manifestation of clobazam toxicity in a child with epilepsy

Developmental Medicine and Child Neurology

Volumn 48, Issue 7, 2006, Pages 612-615

  Aylett, Sarah E ^a,d   Cross, Helen ^b   Berry, Dave ^c  

^a Great Ormond Street Hospital NHS Trust ^*  (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d YOUNG EPILEPSY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOBAZAM; CLONAZEPAM; LAMOTRIGINE; NITRAZEPAM; NORCLOBAZAM; PHENOBARBITAL; PHENYTOIN; PREDNISOLONE; TOPIRAMATE; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; ATAXIA; BENIGN CHILDHOOD EPILEPSY; CASE REPORT; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; EYE MOVEMENT DISORDER; GENERALIZED EPILEPSY; GENETIC VARIABILITY; HUMAN; MALE; NEUROLOGIC DISEASE; OPISTHOTONUS; PRESCHOOL CHILD; PRIORITY JOURNAL; SYMPTOMATOLOGY;

ANTICONVULSANTS; BENZODIAZEPINES; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; HUMANS; MALE; OCULAR MOTILITY DISORDERS; TREATMENT OUTCOME; TRIAZINES;

EID: 33745248083     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1017/S0012162206001289     Document Type: Article

References (20)

1. Asconape JJ, Penry JK. (1982) Use of antiepileptic drugs in the presence of liver and kidney disease: A review. Epilepsia 23 (Suppl.1): 65-80.
2. Aucamp AK. (1982) Aspects of the pharmacokinetics and pharmacodynamics of benzodiazepines with particular reference to clobazam. Drug Development and Research Supplement 1: 117-126.
3. Battino D, Croci D, Granata T, Estienne M, Pisani F, Avanzini G. (1997) Lamotrigine plasma concentrations in children and adults: Influence of age and associated therapy. Ther Drug Monit 19: 620-627.
4. Berry DJ, Wicks JFC, Clarke LA. (1992) Determination of lamotrigine in human plasma by reversed phase HPLC. HPLC '92 (Abstract no. 183).
5. Bun H, Monjanel-Mouterde S, Noel F, Durand A, Cano JP. (1990) Effects of age and antiepileptic drugs on plasma levels and kinetics of clobazam and N-desmethylclobazam. Pharmacol Toxicol 67: 136-140.
6. Canadian Study Group for Childhood Epilepsy. (1998) Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy. Epilepsia 39: 952-959.
7. Contin M, Riva R, Albani F, Baruzzi A. (1999) Effect of felbamate on clobazam and its metabolite kinetics in patients with epilepsy. Ther Drug Monit 21: 604-608.
8. Contin M, Sangiorgi S, Riva R, Parmeggiani A, Albani F, Beruzzi A. (2002) Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam. Ther Drug Monit 24: 737-741.
9. Furuta T, Ohashi K, Kamata T, Takashima M, Kosuge K, Kawasaki T, Hanai H, Kubota T, Ishizaki T, Kaneko E. (1998) Effect of genetic differences in omeprazole metabolism on cure rates for Heliobacter pylori infections and peptic ulcer. Annal Intern Med 129: 1027-1030.
10. Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM, Ghanayem BI. (1994) Evidence that CYP2C19 is the major (S)-mephenytoin 4′-hydroxylase in humans. Biochemistry 33: 1743-1752.
11. Koeppen D, Baruzzi A, Capozza M, Chauvel P, Courjon J, Favel P, Harmant J, Lorenz H, Oller FV, Procaccianti G. (1987) Clobazam in therapy-resistant patients with partial epilepsy: A double-blind placebo-controlled crossover study. Epilepsia 28: 405-506.
12. Monjanel-Mouterde S, Antoni M, Bun H, Botta-Frindlund D, Gauthier A, Durand A, Cano JP. (1994) Pharmacokinetics of a single oral dose of clobazam in patients with liver disease. Pharmacol Toxicol 74: 345-350.
13. Rose W, Kirubakaran C, Scott JX. (2005) Intermittent clobazam therapy in febrile seizures. Indian J Pediatr 72: 31-33.
14. Rosenbaum AH, de la Fuente JR. (1979) Benzodiazepines and tardive dyskinesia. Lancet 8184: 900.
15. Sheth RD, Goulden KJ, Ronen GM. (1994) Aggression in children treated with clobazam for epilepsy. Clin Neuropharmacol 17: 332-337.
16. Shorvon SD. (1995) Clobazam. In: Levy RH, Mattson RH, Meldrum BS, editors. Antiepileptic Drugs, 4th edn. New York: Raven Press Ltd. p 770-771.
17. Stolarek IH, Ford MJ. (1990) Acute dystonia induced by midazolam and abolished by flumazenil. BMJ 300: 614.
18. Streete J, Berry DJ, Newbery JM. (1991) The analysis of clobazam and its metabolite desmethylclobazam by high performance liquid chromatography. Ther Drug Monit 13: 339.
19. Tedeschi G, Riva R, Baruzzi A. (1981) Clobazam plasma concentrations: A pharmacokinetic study in healthy volunteers and data in epileptic patients. Br J Clin Pharmacol 11: 619-621.
20. Volz M, Christ O, Kellner HM, Kuch H, Fehlhaber HW, Gantz D, Hajdu P, Cavagna F. (1979) Kinetics and metabolism of clobazam in animals and man. Br J Clin Pharmacol 7 (Suppl. 1): 41-50.